Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ACTC picked as 1 of 4 Stem Cells Stocks to own.
http://seekingalpha.com/article/127188-four-promising-embyronic-stem-cell-stocks?source=email
Day Traders Like myself will now DUMP again!
.163 X .164 what happened?
i may nibble again tomorrow starting at .0135.
It's like a bouncing ball, it will keep bouncing but just won't go as high on the next bounce. Some refer to it as a dead kitty bounce.
I just play the trend and milk what I can out of a stock. It ALL about the $$. It keeps mama happy!
What sucker bought my shares @ .235 !
Rinse recycle, and do it again!
I love these pinkies!
16 Billion for stem cell research, very nice post!
Armani who has no clue?
WOW ... ACTC up 27% Today and LOOKING Very BULLISH for Tomorrow!
"Bearish Engulfing Candle" Yesterday!
Welcome to the DOWNTREND!
Now ACTC is heading for a Uptrend!
CBAI had a "Bearish Engulfing Candle" formation yesterday. The money flow has turned and the ADX has peaked. My advice today would be to sell at the open. Sorry to say but the run here has come to an end for the time being.
Link shows last trade June 20th 2008? The link appears bad.
Chart holding UP much better than I thought. It is just not ready to do a serious retracement. I have no complaints, 288K strong.
Actually I am not seeing a retreat as I normally would in the past. I think it may sell off some but bounce back and could very well end on an up note. I am not a day trader but a trend trader. The trend now appears to be up with a nice base, it could very well go back to .034-.035 which would only be a good adding opp.
Looking for a rise to .015 with Obama's Money DUMP in Mortgages!
This appears to be a very GOOD Quarter for this sleeper stock. I took advantage when the basing of this stock was .027-.030. For the record I am 288K long at the present time. I am not a long holder of a stock. But I do recall holding IPIX at less than $1 to $25 within 1 MONTH!
Yes it can happen again, but with the current pps I will settle for anything above .50 to 1.00 selling @ 25% lots.
Good Luck to ALL, don't forget to get some Gold for Insurance. I do mean physical Gold, Silver is also very good.
Dew... I would be more than happy to answer that question, but I feel this board is no longer worth the effort.
ranchero the class would be much smaller if there were only 84 million shares in the market. Hence there would not be as many in the class. And if there were no shorts this drug would be on the market today.
Dew...
The size of the class would not be what it is if not for the SEC. Hence the company and its insurers would only be responsible for their %, if found that a wrong was even done.
Lawsuit...
And the actual share count during the class period should/would be available to DNDN in order to know just what % of those in the class vs what is actually in the market in order to know what % they SHOULD only be responsible for.
IE- 2 million shares vs authorized 84 million
or
2 million vs 500 million authorized, naked, broker to broker, broker to dealer & dealer to dealer.
Will the SEC be forced to open up the books for DNDN?
Would DNDN NOT have the right to know?
I believe the lawsuit is not going forward for the can of worms it could open would be a much greater concern to those who are calling the shots on why Provenge is where it is now.
lawsuit?
If discovery commences would not DNDN have the right to know the true share count during the class action period? If so then the SEC would/must open up and supply all shares both naked & legal for that would be the only TRUE way to find out who was actually damaged by DNDN's actions?
For if there are more shares floating around who then would be responsible for those holding shares that were NOT authorized? The SEC? I see this as a can of worms that will be stopped in its tracks. Sorry but the real cover up on why Provenge will be protected. And its not the 483 issue.
Dew.....
Please Call 202-225-2927 "Committee of Energy & Commerce", ask for Matthew. Tell him you have heard that the HHS/IG has an in house investigation going on in reference to Provenge. I too would like to hear that he is telling everyone the same as what he told me. Please confirm and let me/everyone know.
My source tells me that an investigation is currently going on with HHS/IG in reference to the FDA, and it is expected to be completed in a short time period. His words not mine. btw, the two times I have been told this while talking with him on the phone he seemed to be trying to locate a more specific paper giving a more precise time line as if there was a paper pertaining to the investigation.
The rebirth of DNDN coming much sooner than many realize.
Actually its more like "Where's the Beef?".
Everyone would like to hear something that you can sink your teeth into.
Not with King at the helm.
Been away for awhile but used last week as a buying opp. Things may look darkest just before the storm. I have on very good information that the ongoing investigation of the HHS/IG on the FDA is moving closer and closer to an end result. I was not given a specific date as to when it will be completed only that it is soon and way before the interim results. I like many here and on IV have been very active on applying pressure and causing as much headache when possible. I knew I was striking some nerves when an aid from the Committee of Energy & Commerce was calling ME.
I am still in the belief that Good will prevail.
Shelf only a matter of time.
Peregrine is running on fumes as it is and needs the cash. What else can they do? Print money?
It's Big Pharma week next week. I am looking for some interesting news. Mike Huckman said many of the Big Pharma's are in need of pipelines in a BAD way. Add that with how quiet Dendreon has been and the Dec 3rd date for the Naked Shorts could make for a VERY Interesting week! Partner/Buyout and no shorting sets up for a NICE Week ahead Maybe?
Email: foia/pa@sec.gov to obtain the NSS/FTD's. All one has to do is ask. The more the inquiries the better chance of raising a Red Flag. Would you not like to know just how many phantom shares are out there? This will not give the NSS/FTD's that are traded between brokers, ie: broker to broker.
Update FOIA, I sent a request to the SEC: foia/pa@sec.gov and have already received a reply saying that I should receive the requested information within 20 days. I would suggest that everyone to send an email, for it just may help in raising a red flag. I also called the number that was on the yahoo post and talked with the woman who answered the phone. She informed me that many feel bad that the problem of the NSS has not been taken care of better and that the whole agency is suffering for those who are not acting as they should. Seems to me that the SEC is much like the FDA. Remember your tax dollars are paying for this service. I talked with an attorney for the SEC a few days back, he informed me that 20% of the calls to the SEC are NSS related.
A good idea was brought up on yahoo that could bring some attention to the problem with the FTD's / NSS. Anyone can request through the FOIA from the SEC the true count of the FTD's. I was told the turn around time is 3 weeks. The more Inquiries the more attention. Give it a shot and see. Remember its the law.
Email: foia/pa@sec.gov
You bring up a very good point that I liked hearing. The FDA is not raising safety concerns at all. Does that mean as you stated in no# 3 that the population in general explains the imbalance. Could this also be some of the data "patients condition" the FDA requested in June along with the 80 day data numbers. It is a known fact that Dr. Pazdur is very big on survival.
drbio, nice point. Also the panel members were unable to see past Dor not meeting its endpoints. The AC panel seems to have problems and also needs a makeover.
I'm sorry did you say something? Someone is on the wrong board.
ssbum what don't YOU understand? Granted the panel had a hard time seeing past the endpoints that were in the trial design. Buy, Padzur was able to see it, that is why he noted the 80 day and made mention to the 10 day. In ALL TRUTH there was NO set trial design that if the 80 day was used in the 1st place both trials would of met their endpoints. Why do you think the FDA asked the Company to submit different data pertaining to the 2 trials? Don't even bother answering my mind is made up and I am going the distance. But you are just a broken record. Please go back to Yahoo were you belong. BTW you post on yahoo like this board is a joke, so why even come here. For YOU are the real joke. Long and STRONG 200,000 shares average cost .29. PS: while you have been slamming in just the time I have been here you could of made 100% profit! You are real smart, no move ON!
I for one sure hope so. If not anything else it will be setting up the FDA to have more egg on their face if they do NOT approve the drug. If they don't many will wonder just what is the real function of the FDA? Even now many wonder that.
drbio I appreciate your knowledge in explaining the details you have shared with the board. Keep up the good work.
drbio, By Padzur's comments after the vote was taken it appeared to me that he favored the data after seeing the 80 day vs the 50 day. That I believe was the revised data the FDA was looking for in their June meeting. It appears that the FDA wants to approve orBec buts wants to cover their ass by having the revised data as backup. The more I see what has transpired with what has been going on lately with not only orBec but other drugs before the FDA I am really looking for an approval for orBec.
tryn2getrich. This is my 3rd post so it will be the last for today. I am new and read I am limited to just 3 a day. I agree that the panel could not get out of their mind the 50 day endpoint which was in the trial design. Pazdur was able to see it by his comments which led into the discussion of the 80 day endpoint and which I believe was asked for by the FDA in the June meeting.
Let's also keep in mind that David M. Hockenberry member of the Clinical Research Division of the Fred Hutchinson Cancer Research Center and Professor of Medicine, of the University of the Washington School of Medicine wrote a very favorable review just last month which was published in the "Expert Review of Clinical Immunology". Who is also very hands on with what is going on with GVHD verses the AC Panel.
You could also look at what Dor has in the way of Biological Warfare vaccine with Riccin. Add that to the Government grants they have already received would it be in the best interest for the FDA to kill this company when it is the only approved FDA company which can produce the vaccine? This may sound far fetched but it can also be looked upon as a National Security Issue. Riccin was just discovered to be 2000X more lethal than previously thought. I see that level moving up from Beta to Alpha very soon.
Again AIMHO